Clinical trial

Vericiguat and Reverse Remodeling Indices in Heart Failure

NCT07405944

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-11-01

PhasePHASE4

Study timeline

Study start (actual)2025-11-01Date precision: day

Registry last updated2026-09-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Reduced Ejection Fraction (HFrEF)unresolved

Chronic Heart Failureunresolved

Interventions

VericiguatDRUG · verified · RxNorm: vericiguat

Guideline Directed Medical Therapy for Heart Failure (GDMT)DRUG

Sponsors & collaborators

University Medical Centre Ljubljanalead sponsor

Slovenian Research Agencycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07405944 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.